HIPK3 expression level refers to prognosis and sensitivity to chemotherapy, higher HIPK3 expression with badly prognosis and chemoresistance in osteosarcoma and prostate cancer [8,26]. This evidence concerns the gene HIPK3 and prostate carcinoma.